Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from GENinCode UK Ltd. ( (GB:GENI) ).
GENinCode plc has announced a conditional equity fundraising of at least £3.5 million via a placing to institutional investors and a subscription by entities associated with major shareholder Nestor Oller and certain directors, all at an issue price of 1 pence per share, a 47.4% discount to the prior closing price. The placing is expected to raise a minimum of £2.6 million, with a further £0.9 million from the subscription and a potential additional £0.5 million from a separate UK retail offer through the WRAP platform, with proceeds earmarked for US commercialisation and scale-up, EU and UK expansion, and general working capital, subject to shareholder approval at a general meeting on 9 February 2026.
The most recent analyst rating on (GB:GENI) stock is a Sell with a £2.00 price target. To see the full list of analyst forecasts on GENinCode UK Ltd. stock, see the GB:GENI Stock Forecast page.
Spark’s Take on GB:GENI Stock
According to Spark, TipRanks’ AI Analyst, GB:GENI is a Neutral.
The score is held down primarily by weak financial performance (ongoing losses, negative operating cash flow, and declining equity). Technicals add pressure as the stock trades below major moving averages with negative MACD, while valuation is constrained by negative earnings and no dividend yield data.
To see Spark’s full report on GB:GENI stock, click here.
More about GENinCode UK Ltd.
GENinCode plc is a UK-based genetics company specialising in the prevention of cardiovascular disease and the early detection of ovarian cancer. Listed on AIM, it focuses on commercialising its diagnostic technologies in the US, EU and UK markets, targeting growth through expanded clinical adoption and geographic scale-up of its genetic risk assessment products.
Average Trading Volume: 816,018
Technical Sentiment Signal: Strong Sell
Current Market Cap: £5.45M
Find detailed analytics on GENI stock on TipRanks’ Stock Analysis page.